Rex L. Jamison
Email:
Phone:(650) 723-4991 Profile: http://med.stanford.edu/profiles/Rex_Jamison/
Alternate Contact: Academic Appointments
Appointment
Organization
Emeritus (Active) Professor
Emeritus Faculty, Acad Council
Academic Secretary
President, Academic Secretariat
Medicine ;
|
Honors & Awards
Title
Organization
Date(s)
Rhodes Scholar
Rhodes Trust
1955 - 1957
Guggenheim Fellow
John Simon Guggenheim Foundation
1977 - 1978
Fellow
American College of Physicians
1985
Fellow
Royal College of Physicians (London)
1998
Champion of Hope Award
National Kidney Foundation of Northern California
1999
Administrative Appointments
Title
Organization
Start Year
End Year
Academic Secretary to the University
Stanford University
2007
-
Professional Education
Degree
Awarding Institution
Field of Study
Year of Graduation
A.B.
University of Iowa
General Science
1955
B.A.
Oxford University
Physiology
1957
M.D.
Harvard Medical School
Medicine
1960
M.A.
Oxford University
Physiology
1961
Web Site Links
Research/Lab website:
Description of research
Research Interests
1. The Dept. of Veterans Affairs Cooperative Studies Program, "Homocysteinemia in Kidney Disease and End Stage Renal Disease", or "The Homocysteine Study" (HOST), for short, was a prospective, randomized, two-arm, double blind, placebo-controlled clinical trial in patients with advanced chronic kidney disease. Its aim was to determine if large doses of folic acid, vitamins B6 and B12, to lower plasma homocysteine levels, would reduce the mortality (primary endpoint) of patients with advanced chronic kidney disease or end stage kidney disease. Secondary endpoints included symptomatic myocardial infarction, disabling stroke, and amputation of all or part of a leg, a composite of the primary and foregoing secondary endpoints, and in hemodialysis patients, thrombosis of the vascular access. Thirty-six medical centers participated; 2,056 patients were enrolled. The duration of the study was 6 years. The results showed no difference in the number of deaths or cardiovascular events between the treatment and the placebo groups. These findings do not support the widespread use of supplemental vitamins in patients with kidney disease to improve survival or reduce cardiovascular disease.
2. A substudy of HOST, "Genetic Tissue Banking for the HOST Trial", involved the collection and storage of DNA from blood samples taken from HOST subjects. The intent is to determine whether polymorphisms of candidate genes in patients with advanced chronic kidney disease puts them at increased risk for cardiovascular morbidity and mortality or interferes with treatment to lower plasma homocysteine levels.
3. A second substudy of HOST, sponsored by the NIH, "Kidney Disease, Hyperhomocysteinemia and Cognitive Function" has been completed. The purpose was to see if vitamin treatment lowered the risk or slowed the progression of cognitive impairment in patients with chronic kidney disease. The results are pending.
4. I have long standing interest in the urinary concentration mechanism, particularly the countercurrent hypothesis of the loops of Henle and the countercurrent exchange role played by the capillaries of the renal medulla (the vasa recta).
2. A substudy of HOST, "Genetic Tissue Banking for the HOST Trial", involved the collection and storage of DNA from blood samples taken from HOST subjects. The intent is to determine whether polymorphisms of candidate genes in patients with advanced chronic kidney disease puts them at increased risk for cardiovascular morbidity and mortality or interferes with treatment to lower plasma homocysteine levels.
3. A second substudy of HOST, sponsored by the NIH, "Kidney Disease, Hyperhomocysteinemia and Cognitive Function" has been completed. The purpose was to see if vitamin treatment lowered the risk or slowed the progression of cognitive impairment in patients with chronic kidney disease. The results are pending.
4. I have long standing interest in the urinary concentration mechanism, particularly the countercurrent hypothesis of the loops of Henle and the countercurrent exchange role played by the capillaries of the renal medulla (the vasa recta).
Community and International Work
- Rhodes Marshall Panel, Stanford University, Stanford University More »
Publications
- Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, Gaziano JM "Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial." JAMA 2007; 298: 10: 1163-70 More »
- Jamison RL, Hartigan P, Gaziano JM, Fortmann SP, Goldfarb DS, Haroldson JA, Lavori P, McCully KS, Robinson K "Design and statistical issues in the Homocysteinemia in Kidney and End Stage Renal Disease (HOST) Study." Clinical Trials 2004; 1: 5: 451-460 More »
- Pallone TL, Turner MR, Edwards A, Jamison RL "Countercurrent exchange in the renal medulla." Am J Physiol Regul Integr Comp Physiol 2003; 284: 5: R1153-75 More »
- Lohe A, Yeh I, Hyver T, Pratt R, Jamison R "Natriuretic peptide B receptor and C-type natriuretic peptide in the rat kidney." J Am Soc Nephrol 1995; 6: 6: 1552-8 More »
- Pallone TL, Work J, Myers RL, Jamison RL "Transport of sodium and urea in outer medullary descending vasa recta." J Clin Invest 1994; 93: 1: 212-22 More »
94 publications: view full list
